Halozyme Therapeutics shares owned by Royal London Asset Management
Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Royal London Asset Management
from 13F filings
Historical chart of Royal London Asset Management investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Royal London Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Royal London Asset Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $84M | 1.1M | 73.34 |
| 2025-06-30 | $57M | 1.1M | 52.02 |
| 2025-03-31 | $32M | 496k | 63.81 |
More positions owned by Royal London Asset Management
View all positions for Royal London Asset Management